Angiogenesis
Angiogenesis(血管生成)
Angiogenesis 相关产品(355)
- GC43514D-myo-Inositol-1,3,4,5,6-pentaphosphate (ammonium salt)纯度: >98.00%
An anticancer inositol phosphate
- GC43515D-myo-Inositol-1,3,4,5,6-pentaphosphate (sodium salt)纯度: >98.00%
An anticancer inositol phosphate
- GC43727Ganglioside GD1a mixture (sodium salt)CAS: 12707-58-3纯度: >98.00%
A mixture of ganglioside G D1a
- GC44956StreptochlorinCAS: 120191-51-7纯度: >98.00%
A bacterial metabolite with diverse biological activities
- GC44966Sucrose octasulfate (potassium salt)CAS: 73264-44-5纯度: >95.00%
An alkaline aluminum?sucrose complex
- GC45677Anlotinib (hydrochloride)CAS: 1058157-76-8纯度: >95.00%
A neuropeptide with diverse biological activities
- GC45767Dovitinib-d8CAS: 1246819-84-0纯度: >99.00%
An internal standard for the quantification of dovitinib
- GC45769Vandetanib-d6CAS: 1174683-49-8纯度: >99.00%
An internal standard for the quantification of vandetanib
- GC45880Cimetidine-d3CAS: 1185237-29-9纯度: >99.00%
An internal standard for the quantification of cimetidine
- GC45922(±)11(12)-EET-d11 methyl ester纯度: >99.00%
A neuropeptide with diverse biological activities
- GC46304(±)-Nebivolol-d4 (hydrochloride)CAS: 2701283-32-9纯度: >99.00%
A neuropeptide with diverse biological activities
- GC4647418-DeoxyherboxidieneCAS: 1200128-66-0纯度: >70.00%
A bacterial metabolite with antiangiogenic activity
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC43514 | D-myo-Inositol-1,3,4,5,6-pentaphosphate (ammonium salt) | - | >98.00% | |
An anticancer inositol phosphate | ||||
| GC43515 | D-myo-Inositol-1,3,4,5,6-pentaphosphate (sodium salt) | - | >98.00% | |
An anticancer inositol phosphate | ||||
| GC43727 | Ganglioside GD1a mixture (sodium salt) | 12707-58-3 | >98.00% | |
A mixture of ganglioside G D1a | ||||
| GC43732 | Ganglioside GM3 Mixture (sodium salt) | 54827-14-4 | >98.00% | |
A mixture of ganglioside G M3 | ||||
| GC43803 | HA-1077 (hydrochloride) | 203911-27-7 | >98.00% | |
A ROCK inhibitor | ||||
| GC44290 | NAADP (sodium salt) | - | >95.00% | |
A secondary messenger that induces calcium mobilization | ||||
| GC44358 | Nebivolol O-β-D-Glucuronide | - | >95.00% | |
An active metabolite of nebivolol | ||||
| GC44465 | NSC 12 | 102586-30-1 | >98.00% | |
An FGF inhibitor | ||||
| GC44475 | NVP-BEZ235 (hydrochloride) | 2319647-83-9 | >98.00% | |
Dual inhibitor of PI3K and mTOR | ||||
| GC44584 | PD 168368 | 204066-82-0 | >95.00% | |
An antagonist of NMB receptors | ||||
| GC44800 | Quininib | 143816-42-6 | - | |
A CysLT 1 and CysLT 2 receptor antagonist | ||||
| GC44956 | Streptochlorin | 120191-51-7 | >98.00% | |
A bacterial metabolite with diverse biological activities | ||||
| GC44966 | Sucrose octasulfate (potassium salt) | 73264-44-5 | >95.00% | |
An alkaline aluminum?sucrose complex | ||||
| GC45054 | Tie2 Inhibitor 7 | 1020412-97-8 | >95.00% | |
Blocks Tie2 kinase activity | ||||
| GC45269 | (±)10(11)-DiHDPA | 1345275-22-0 | >98.00% | |
An epoxygenase metabolite of DHA | ||||
| GC45677 | Anlotinib (hydrochloride) | 1058157-76-8 | >95.00% | |
A neuropeptide with diverse biological activities | ||||
| GC45688 | STX140 | 401600-86-0 | >98.00% | |
An estrogen sulfamate | ||||
| GC45767 | Dovitinib-d8 | 1246819-84-0 | >99.00% | |
An internal standard for the quantification of dovitinib | ||||
| GC45769 | Vandetanib-d6 | 1174683-49-8 | >99.00% | |
An internal standard for the quantification of vandetanib | ||||
| GC45798 | Rhein-13C4 | 1189928-10-6 | >95.00% | |
An internal standard for the quantification of rhein | ||||
| GC45880 | Cimetidine-d3 | 1185237-29-9 | >99.00% | |
An internal standard for the quantification of cimetidine | ||||
| GC45922 | (±)11(12)-EET-d11 methyl ester | - | >99.00% | |
A neuropeptide with diverse biological activities | ||||
| GC46304 | (±)-Nebivolol-d4 (hydrochloride) | 2701283-32-9 | >99.00% | |
A neuropeptide with diverse biological activities | ||||
| GC46474 | 18-Deoxyherboxidiene | 1200128-66-0 | >70.00% | |
A bacterial metabolite with antiangiogenic activity | ||||